跳至主要内容
临床试验/EUCTR2009-012817-23-FR
EUCTR2009-012817-23-FR进行中(未招募)1 期

tilisation d’un surfactant exogène chez des nouveau-nés grands prématurés présentant une détresse respiratoire sévère en prévention de la dysplasie bronchopulmonaire - Etude CURDYS

Maternite Regionale Universitaire de Nancy0 个研究点目标入组 100 人开始时间: 2009年7月10日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Critères d’inclusion : tout nouveau-né d’âge gestationnel inférieur à 33 semaines d’aménorrhée toujours sous ventilation assistée conventionnelle ou par oscillations à hautes fréquences (OHF), après 14+2 jours de vie, avec une FiO2 > 35% et/ou un Index d’Oxygénation (IO= PMA*FiO2 / PaO2) > 8 (PMA = pression moyenne dans les voies aériennes).
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • infection évolutive (CRP>30mg/l) non maîtrisée par un traitement antibiotique adapté; utilisation de corticoïdes en période postnatale; pathologie neurologique ou malformative remettant en cause la pertinence de l’extubation;intervention chirurgicale < 72 h; refus d’autorisation parentale

研究者

发起方
Maternite Regionale Universitaire de Nancy

相似试验

进行中(未招募)
1 期
Comparison of two respiratory severity thresholds as indications for the administration of exogenous surfactant in preterm infants with respiratory disease.
EUCTR2019-002923-13-ITAZIENDA OSPEDALIERO-UNIVERSITARIA OSPEDALI RIUNITI DI ANCONA200
尚未招募
不适用
To compare the outcomes of neonates who received surfactant for breathing difficulty with neonates who did not, in an advanced neonatal care unit in South India.
CTRI/2022/05/042379Riya Asokan
进行中(未招募)
1 期
A Clinical Trial of Nebulized Bovactant (Alveofact ®) for the Treatment of Moderate to Severe COVID-19COVID-19 infection in patients requiring endotrachael intubationMedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestations
EUCTR2020-001886-35-GBniversity Hospital Southampton NHS Foundation Trust20
招募中
不适用
Early intratracheal treatment with surfactant plus steroids (SurPluS) in low birth-weight premature infants following preterm premature rupture of the membranes-clincal course and outcomeP23.9P25.1P26.8P28.5P27.1P52.0P52.1P52.2P52.4P36.9P39.9P77P78.0P91.1H35.1Intracerebral (nontraumatic) haemorrhage of fetus and newbornBacterial sepsis of newborn, unspecifiedInfection specific to the perinatal period, unspecifiedCongenital pneumonia, unspecifiedPneumothorax originating in the perinatal periodOther pulmonary haemorrhages originating in the perinatal periodRespiratory failure of newbornBronchopulmonary dysplasia originating in the perinatal periodIntraventricular (nontraumatic) haemorrhage, grade 1, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 2, of fetus and newbornIntraventricular (nontraumatic) haemorrhage, grade 3, and grade 4 of fetus and newbornNecrotizing enterocolitis of fetus and newbornPerinatal intestinal perforationAcquired periventricular cysts of newbornRetinopathy of prematurity
DRKS00021504niversität zu Lübeck186
招募中
不适用
INTRA-AMNIOTIC SURFACTANT USE FOR PREVENTING RESPIRATORY DISTRESS SYNDROME IN PRETERM BIRTH
CTRI/2015/12/006399Project under thesis at All India Institute of Medical Sciences New Delhi40